Category Health/Medical

Simple 20-20-20 Screen Rule really does Help with Eye Strain, Research Shows

eye
Credit: Unsplash/CC0 Public Domain

It’s long been recommended as a way of easing eye strain while working at a computer screen. Now the 20-20-20 rule—taking a break of at least 20 seconds, every 20 minutes, to look at least 20 feet away—has been confirmed by scientists at Aston University to help ease some of the symptoms of prolonged computer use.

It’s estimated that at least half of people using computers in their regular work have some form of digital eye strain, resulting in eye surface problems including irritation and dryness, or vision issues such as headaches or blurred vision. Humans normally blink around 15 times each minute. When staring at screens, this number decreases generally to half that rate or less...

Read More

High-Fat Diets Trigger Inflammatory Immune Cell Generation in Bone

High-fat diets drive the production of inflammatory immune cells in the bone  marrow of mice
High-fat diets trigger inflammatory immune cell generation in bone

A study suggests that high-fat diets fuel the creation of inflammatory immune cells in the bone marrow of mice. The results may help explain how high-fat diets trigger inflammation, which can contribute to the development of insulin resistance, type 2 diabetes and other complications in individuals with obesity.

An invasion of inflammatory immune cells, called monocytes, into fat tissue is a hallmark of obesity, but what leads to this harmful phenomenon is unclear. Many immune cells, including monocytes, are produced in the bone marrow, which is very sensitive to environmental changes. Scientists have already shown that fat cells in the bone marrow rapidly expand in response to a high-fat diet.

“We wanted to know ...

Read More

Rheumatoid Arthritis Drug Effective against Myasthenia Gravis

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

Early intervention with rituximab, a drug used in the treatment of rheumatoid arthritis (RA), can reduce the risk of deterioration in myasthenia gravis, an autoimmune disease that causes loss of muscle control. This is according to a randomized clinical study led by researchers at Karolinska Institutet in Sweden and published in the journal JAMA Neurology.

“Patients with new onset myasthenia who received rituximab as a complement to standard of care showed greater improvement compared with patients who were given a placebo,” says Fredrik Piehl, professor at the Department of Clinical Neuroscience, Karolinska Institutet, and the study’s principal investigator...

Read More

Diet could play a role in Cognitive Function across Diverse Races and Ethnicities

Diet could play a role in cognitive function across diverse races and ethnicities
Metabolite—global cognitive function analyses flowchart. Step A: Replication and generalization analysis in HCHS/SOL of previously reported single metabolites associated with global cognitive function in BPRHS (Step A). Step B: Replication and generalization testing in HCHS/SOL of association of the metabolite risk score (MRS) constructed in BPRHS with extremes of global cognition. Step C: Generalization of single metabolite associations with global cognitive function in the Atherosclerosis Risk In Communities (ARIC) dataset. Step D: Two-sample Mendelian randomization (MR) analysis to evaluate causal relationships between the single metabolites and global cognitive function. Step E: Associations between the Mediterranean diet and single metabolites...
Read More